KKR was named firm of the year and won the large-cap fundraising prize at the 2017 AVCJ Private Equity & Venture Capital Awards. Yichen Zhang of CITIC Capital was honored as PE professional of the year while PAG Asia Capital and an MBK Partners and Goldman Sachs-led consortium took the awards for large-cap deal and large-cap exit, respectively.
A total of 18 prizes were presented, including three awards to celebrate the 30th anniversary of AVCJ – by marking the leading investment from each decade in which the publication has been active. KKR...
Even if pan-Asian buyout firms aren't actively pursuing investments in internet-related businesses, they cannot ignore the potential disruptive impact of these technologies on other portfolio companies
Mekong Capital's 6.3x return on its investment in Vietnam-based pharmaceuticals player Traphaco involved turning the company's distribution model on its head, as well as supporting expansion and improving governance
China Renaissance has added dedicated healthcare and mezzanine debt strategies to its existing growth-stage private equity offering as part of efforts to more than treble its assets under management (AUM) over the next three years.
China Venture Capital Fund, a VC vehicle backed by the Chinese government, and ChinaEquity Group have jointly led a RMB670 million ($101 million) round for 3D Medicines, which focuses on personalized diagnostics and treatment for cancer.